<p>Flow diagram indicating number of women who assented and children enrolled into the study, randomized to neonatal or infant PCV7 or control groups and number excluded or lost to follow-up in the course of the study. PCV = 7-valent pneumococcal conjugate vaccine; N = Neonatal group; I = Infant group; C = control group; LTFU = lost to follow-up (includes not located, withdrew consent, migration). Numbers (n) are total excluding LTFU and protocol violations.</p
<p>CONSORT 2010 Flow Diagram. The schema graphically outlines the design and conduct of the clinical...
<p>Of 10,463 patients approached for inclusion in study, 8,715 consented. Because patients were retr...
<p>During the study period (i.e. day of life 4 until day of life 28), 25 infants were evaluated for ...
<p>A flowchart of the completed preceding neonatal PCV7 trial is published elsewhere [<a href="http:...
<p>A flow diagram describing the study population included in the study group (n = 36) as well as th...
<p>Group A1, participants receiving PCECV according to the 4-site/1-week ID regimen; Group A2, parti...
<p>Number of subjects assessed for eligibility, enrolled and randomized to study vaccine or placebo....
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p>Flow diagram showing the number of individuals enrolled, randomized to vaccine or placebo, follow...
<p>Flow diagram of participation in a longitudinal study, measuring baseline acceptance and subseque...
<p>Patient allocation and analyses performed throughout the study are depicted in Figure 1: RSV sign...
<p><sup>a</sup>Screening data had not been reported before the database freeze for the analysis publ...
The flow diagram indicates maternal and infant participation at the stages of study enrollment, deli...
<p><b><sup>#</sup>Reasons for exclusions of cases:</b> HIV (+) (3), transfer to other hospital becau...
<p>(A) A total of 31 volunteers were randomized (21 to the MVA-B arm and 10 to the placebo arm) but ...
<p>CONSORT 2010 Flow Diagram. The schema graphically outlines the design and conduct of the clinical...
<p>Of 10,463 patients approached for inclusion in study, 8,715 consented. Because patients were retr...
<p>During the study period (i.e. day of life 4 until day of life 28), 25 infants were evaluated for ...
<p>A flowchart of the completed preceding neonatal PCV7 trial is published elsewhere [<a href="http:...
<p>A flow diagram describing the study population included in the study group (n = 36) as well as th...
<p>Group A1, participants receiving PCECV according to the 4-site/1-week ID regimen; Group A2, parti...
<p>Number of subjects assessed for eligibility, enrolled and randomized to study vaccine or placebo....
<p>CONSORT flow diagram showing subject recruitment and follow up. Subjects were allocated to Groups...
<p>Flow diagram showing the number of individuals enrolled, randomized to vaccine or placebo, follow...
<p>Flow diagram of participation in a longitudinal study, measuring baseline acceptance and subseque...
<p>Patient allocation and analyses performed throughout the study are depicted in Figure 1: RSV sign...
<p><sup>a</sup>Screening data had not been reported before the database freeze for the analysis publ...
The flow diagram indicates maternal and infant participation at the stages of study enrollment, deli...
<p><b><sup>#</sup>Reasons for exclusions of cases:</b> HIV (+) (3), transfer to other hospital becau...
<p>(A) A total of 31 volunteers were randomized (21 to the MVA-B arm and 10 to the placebo arm) but ...
<p>CONSORT 2010 Flow Diagram. The schema graphically outlines the design and conduct of the clinical...
<p>Of 10,463 patients approached for inclusion in study, 8,715 consented. Because patients were retr...
<p>During the study period (i.e. day of life 4 until day of life 28), 25 infants were evaluated for ...